Acadia Pharmaceuticals insider sells 11,421 shares at $26.08
An Acadia Pharmaceuticals insider sold 11,421 shares of common stock in an open-market transaction on June 26, 2026.
This sale is the insider’s largest single open-market sale on record, exceeding the previous sale of 5,401 shares on May 26, 2026.
The transaction represented 46.60% of the insider’s direct holdings prior to the sale, leaving 13,088 shares directly held post-transaction.